3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
2
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
55
Prostatic Neoplasms
46
Glioblastoma
28
Brain Neoplasms
25
Neoplasms
23
Glioma
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
18
Carcinoma, Hepatocellular
14
Gliosarcoma
13
Colorectal Neoplasms
12
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
11
Rectal Neoplasms
10
Lymphoma, Non-Hodgkin
10
Oligodendroglioma
9
Melanoma
9
Central Nervous System Neoplasms
9
Astrocytoma
9
Lymphoma
8
Head and Neck Neoplasms
8
Esophageal Neoplasms
8
Colonic Neoplasms
8
Ependymoma
7
Squamous Cell Carcinoma of Head and Neck
6
Pancreatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Carcinoma, Renal Cell
6
Breast Neoplasms, Male
6
Ovarian Neoplasms
5
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01336803
2023-12-27
Osteosarcoma
Stanford University
Phase 2
Completed
32 enrolled
11 charts